Bibliographical investigation of complementary alternative medicines for osteoarthritis and rheumatoid arthritis

Geriatrics and Gerontology International

Volumn 9, Issue 1, 2009, Pages 29-40

  Kikuchi, Motoo ^a,b   Matsuura, Kentaro ^a   Matsumoto, Yoshifuji ^a   Inagaki, Toshiaki ^b   Ueda, Ryuzo ^c  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b Nagoya City University East Medical Center   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Complementary alternative medicine; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

ASTAXANTHIN; BROMELAIN; CAPSAICIN; CHINESE DRUG; CHONDROITIN; CHONDROITIN SULFATE; DIACETYLRHEIN; DIMETHYL SULFONE; FISH OIL; GAMMA LINOLENIC ACID; GLUCOSAMINE; HERBACEOUS AGENT; HYALURONIC ACID; LINOLENIC ACID; LYPRINOL; OCTACOSANOL; OXACEPROL; PHLOGENZYM; PIASCLEDINE; PINENE; PLACEBO; POLYUNSATURATED FATTY ACID; PRIMROSE OIL; PROLINE; PYCNOGENOL; QUERCETIN; THIOCTIC ACID; UBIDECARENONE; UNINDEXED DRUG; WOBENZYM;

ALTERNATIVE MEDICINE; ANALGESIA; ARTICLE; BIOLOGICAL THERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; HUMAN; JAPAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

AGED; ARTHRITIS, RHEUMATOID; BIBLIOGRAPHY AS TOPIC; COMPLEMENTARY THERAPIES; HUMANS; INTERNET; OSTEOARTHRITIS;

EID: 61549096485     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2008.00503.x     Document Type: Article

References (132)

1. Pullar T, Pullar T, Capell HA, Millar A, Brooks RG. Alternative medicine: Cost and subjective benefit in rheumatoid arthritis. Br Med J 1982; 285: 1629-1631.
2. Berman BM, Hartnoll S, Bausell B. CAM evaluation comes into the mainstream: NIH specialized Centers of research and the University of Maryland Center for Alternative Medicine Research in Arthritis. Complement Ther Med 2000; 8: 119-122.
3. Kaboli PJ, Doebbeling BN, Saag KG, Rosenthal GE. Use of complementary and alternative medicine by older patients with arthritis: A population-based study. Arthritis Rheum 2001; 45: 398-403.
4. Kim HA, Seo YI. Use of complementary and alternative medicine by arthritis patients in a university hospital clinic serving rheumatology patients in Korea. Rheumatol Int 2003; 23: 277-281.
5. Sleath B, Callahan L, DeVellis RF, Sloane PD. Patients' perceptions of primary care physicians' participatory decision-making style and communication about complementary and alternative medicine for arthritis. J Altern Complement Med 2005; 11: 449-453.
6. Quandt SA, Chen H, Grzywacz JG, Bell RA, Lang W, Arcury TA. Use of complementary and alternative medicine by persons with arthritis: results of the National Health Interview Survey. Arthritis Rheum 2005; 53: 748-755.
7. Gray D. The treatment strategies of arthritis sufferers. Soc Sci Med 1985; 21: 507-515.
8. Lequesne M. Alternative therapies for high-risk elderly rheumatic patients. Gerontology 1988; 34 (Suppl 1): 33-41.
9. Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B. Treatment of osteoarthritis with a herbomineral formulation: A double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 1991; 33: 91-95.
10. Nordstrom DC, Honkanen VE, Nasu Y, Antila E, Friman C, Konttinen YT. Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: Flaxseed vs. safflower seed. Rheumatol Int 1995; 14: 231-234.
11. Sohail MT, Chaudhry MI, Usman MK, Mian T, Ishaq MN. Efficacy and tolerance of atrisin in degenerative and inflammatory joint disorders. Phytother Res 2005; 19: 365-368.
12. Blotman F, Maheu E, Wulwik A, Caspard H, Lopez A. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev Rhum Engl Ed 1997; 64: 825-834.
13. Maheu E, Mazieres B, Valat JP et al. Symptomatic efficacy of avocado/ soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: A prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum 1998; 41: 81-91.
14. Appelboom T, Schuermans J, Verbruggen G, Henrotin Y, Reginster JY. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study. Scand J Rheumatol 2001; 30: 242-247.
15. Little CV, Parsons T. Herbal therapy for treating osteoarthritis. Cochrane Database Syst Rev 2001; 1: CD002947.
16. Lequesne M, Maheu E, Cadet C, Dreiser RL. Structural effect of avocado/ soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Rheum 2002; 47: 50-58.
17. Ernst E. Avocado-soybean unsaponifiables (ASU) for osteoarthritis - a systematic review. Clin Rheumatol 2003; 22: 285-288.
18. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with blackcurrant seed oil. Br J Rheumatol 1994; 33: 847-852.
19. Pullman-Mooar S, Laposata M, Lem D et al. Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid. Arthritis Rheum 1990; 33: 1526-1533.
20. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee - a randomized double blind placebo controlled trial. Phytomedicine 2003; 10: 3-7.
21. Walker AF, Bundy R, Hicks SM, Middleton RW. Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults. Phytomedicine 2002; 9: 681-686.
22. Deal CL, Schnitzer TJ, Lipstein E et al. Treatment of arthritis with topical capsaicin: A double-blind trial. Clin Ther 1991; 13: 383-395.
23. McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol 1992; 19: 604-607.
24. Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin. A meta-analysis. Eur J Clin Pharmacol 1994; 46: 517-522.
25. McCleane G. The analgesic efficacy of topical capsaicin is enhanced by glyceryl trinitrate in painful osteoarthritis: A randomized, double blind, placebo controlled study. Eur J Pain 2000; 4: 355-360.
26. Gagnier JJ, van Tulder M, Berman B, Bombardier C. Herbal medicine for low back pain. Cochrane Database Syst Rev 2006; 2: CD004504.
27. Piscoya J, Rodriguez Z, Bustamante SA, Okuhama NN, Miller MJ, Sandoval M. Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: Mechanisms of action of the species Uncaria guianensis. Inflamm Res 2001; 50: 442-448.
28. Mur E, Hartig F, Eibl G, Schirmer M. Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of uncaria tomentosa for the treatment of rheumatoid arthritis. J Rheumatol 2002; 29: 678-681.
29. Miller MJ, Mehta K, Kunte S et al. Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: A randomized controlled trial [ISRCTN38432711]. J Inflamm (Lond) 2005; 2: 11.
30. Hesslink R Jr, Armstrong D 3rd, Nagendran MV, Sreevatsan S, Barathur R. Cetylated fatty acids improve knee function in patients with osteoarthritis. J Rheumatol 2002; 29: 1708-1712.
31. Kraemer WJ, Ratamess NA, Anderson JM et al. Effect of a cetylated fatty acid topical cream on functional mobility and quality of life of patients with osteoarthritis. J Rheumatol 2004; 31: 767-774.
32. Kraemer WJ, Ratamess NA, Maresh CM et al. A cetylated fatty acid topical cream with menthol reduces pain and improves functional performance in individuals with arthritis. J Strength Cond Res 2005; 19: 475-480.
33. Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 1996; 23: 1385-1391.
34. Bourgeois P, Chales G, Dehais J, Delcambre B, Kuntz JL, Rozenberg S. Efficacy and tolerability of chondroitin sulfate 1200mg/day vs chondroitin sulfate 3×400mg/day vs placebo. Osteoarthritis Cartilage 1998; 6 (Suppl A): 25-30.
35. Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 1998; 6 (Suppl A): 31-36.
36. Uebelhart D, Thonar EJ, Delmas PD, Chantraine A, Vignon E. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: A pilot study. Osteoarthritis Cartilage 1998; 6 (Suppl A): 39-46.
37. Leeb BF, Schweitzer H, Montag K, Smolen JS. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2000; 27: 205-211.
38. Mazieres B, Combe B, Phan Van A, Tondut J, Grynfeltt M. Chondroitin sulfate in osteoarthritis of the knee: A prospective, double blind, placebo controlled multicenter clinical study. J Rheumatol 2001; 28: 173-181.
39. Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: A comprehensive meta-analysis. Arch Intern Med 2003; 163: 1514-1522.
40. Uebelhart D, Malaise M, Marcolongo R et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: A one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage 2004; 12: 269-276.
41. Michel BA, Stucki G, Frey D et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: A randomized, controlled trial. Arthritis Rheum 2005; 52: 779-786.
42. Clegg DO, Reda DJ, Harris CL et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006; 354: 795-808.
43. Distler J, Anguelouch A. Evidence-based practice: Review of clinical evidence on the efficacy of glucosamine and chondroitin in the treatment of osteoarthritis. J Am Acad Nurse Pract 2006; 18: 487-493.
44. Wegener T, Lupke NP. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC). Phytother Res 2003; 17: 1165-1172.
45. Gagnier JJ, Chrubasik S, Manheimer E. Harpgophytum procumbens for osteoarthritis and low back pain: A systematic review. BMC Complement Altern Med 2004; 4: 13.
46. Nguyen M, Dougados M, Berdah L, Amor B. Diacerhein in the treatment of osteoarthritis of the hip. Arthritis Rheum 1994; 37: 529-536.
47. Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the chondromodulating effect of diacerein in OA of the hip. Arthritis Rheum 2001; 44: 2539-2547.
48. Pham T, Le Henanff A, Ravaud P, Dieppe P, Paolozzi L, Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis 2004; 63: 1611-1617.
49. Fidelix TS, Soares BG, Trevisani VF. Diacerein for osteoarthritis. Cochrane Database Syst Rev 2006; 1: CD005117.
50. Teekachunhatean S, Kunanusorn P, Rojanasthien N et al. Chinese herbal recipe versus diclofenac in symptomatic treatment of osteoarthritis of the knee: A randomized controlled trial [ISRCTN70292892]. BMC Complement Altern Med 2004; 4: 19.
51. Biswas NR, Biswas K, Pandey M, Pandy RM. Treatment of osteoarthritis, rheumatoid arthritis and non-specific arthritis with a herbal drug: A double-blind, active drug controlled parallel study. JK Pract 1998; 5: 129-132.
52. Akhtar NM, Naseer R, Farooqi AZ, Aziz W, Nazir M. Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee - a double-blind prospective randomized study. Clin Rheumatol 2004; 23: 410-415.
53. Belch JJ, Ansell D, Madhok R, O'Dowd A, Sturrock RD. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: A double blind placebo controlled study. Ann Rheum Dis 1988; 47: 96-104.
54. Brzeski M, Madhok R, Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs. Br J Rheumatol 1991; 30: 370-372.
55. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med 1993; 119: 867-873.
56. Zurier RB, Rossetti RG, Jacobson EW et al. γ-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis Rheum 1996; 39: 1808-1817.
57. Bliddal H, Rosetzsky A, Schlichting P et al. A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 2000; 8: 9-12.
58. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 2001; 44: 2531-2538.
59. Ryttig K, Schlamowitz PV, Warnoe O, Wilstrup F. Gitadyl versus ibuprofen in patients with osteoarthrosis. The result of a double-blind, randomized cross-over study. Ugeskr Laeger 1991; 153: 2298-2299.
60. da Camara CC, Dowless GV. Glucosamine sulfate for osteoarthritis. Ann Pharmacother 1998; 32: 580-587.
61. Reginster JY, Deroisy R, Rovati LC et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomised, placebo-controlled clinical trial. Lancet 2001; 357: 251-256.
62. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: A 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002; 162: 2113-2123.
63. Bruyere O, Honore A, Ethgen O etal. Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis Cartilage 2003; 11: 1-5.
64. Bruyere O, Pavelka K, Rovati LC et al. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: Evidence from two 3-year studies. Menopause 2004; 11: 138-143.
65. Towheed TE, Maxwell L, Anastassiades TP et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005; 2: CD002946.
66. Poolsup N, Suthisisang C, Channark P, Kittikulsuth W. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Ann Pharmacother 2005; 39: 1080-1087.
67. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis. JAMA 2000; 283: 1469-1475.
68. Rein E, Kharazmi A, Winther K. A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis -a double-blind, placebo-controlled, randomised trial. Phytomedicine 2004; 11: 383-391.
69. Winther K, Apel K, Thamsborg G. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: A randomized, double-blind, placebo-controlled clinical trial. Scand J Rheumatol 2005; 34: 302-308.
70. Kremer JM, Jubiz W, Michalek A et al. Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. Ann Intern Med 1987; 106: 497-503.
71. Lau CS, Morley KD, Belch JJ. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - a double-blind placebo controlled study. Br J Rheumatol 1993; 32: 982-989.
72. Cho SH, Jung YB, Seong SC et al. Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel (Perna Canaliculus) in patients with osteoarthritis of the hip and knee: A multicenter 2-month clinical trial. Allerg Immunol, 2003; 35: 212-216.
73. Cobb CS, Ernst E. Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: The effectiveness of the New Zealand green-lipped mussel Perna canaliculus. Clin Rheumatol 2006; 25: 275-284.
74. Randall C, Randall H, Dobbs F, Hutton C, Sanders H. Randomized controlled trial of nettle sting for treatment of base-of-thumb pain. J R Soc Med 2000; 93: 305-309.
75. Bauer HW, Klasser M, von Hanstein KL et al. Oxaceprol is as effective as diclofenac in the therapy of osteoarthritis of the knee and hip. Clin Rheumatol 1999; 18: 4-9.
76. Herrmann G, Steeger D, Klasser M et al. Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac. Clin Rheumatol 2000; 19: 99-104.
77. Witte S, Lasek R, Victor N. Meta-analysis of the efficacy of adenosylmethionine and oxaceprol in the treatment of osteoarthritis. Orthopade 2002; 31: 1058-1065.
78. Tilwe GH, Beria S, Turakhia NH, Daftary GV, Schiess W. Efficacy and tolerability of oral enzyme therapy as compared to diclofenac in active osteoarthrosis of knee joint: An open randomized controlled clinical trial. J Assoc Physicians India 2001; 49: 617-621.
79. Klein G, Kullich W, Schnitker J, Schwann H. Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol 2006; 24: 25-30.
80. Huber B. Therapy of degenerative rheumatic diseases. Need for additional analgesic medication with Phytodolor N. Fortschr Med 1991; 109: 248-250.
81. Cleland LG, French JK, Betts WH, Murphy GA, Elliott MJ. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 1988; 15: 1471-1475.
82. van der Tempel H, Tulleken JE, Limburg PC, Muskiet FA, van Rijswijk MH. Effects of fish oil supplementation in rheumatoid arthritis. Ann Rheum Dis 1990; 49: 76-80.
83. Astorga G, Cubillos A, Masson L, Silva JJ. Active rheumatoid arthritis: effect of dietary supplementation with omega-3 oils. A controlled double-blind trial. Rev Med Chil 1991; 119: 267-272.
84. Kjeldsen-Kragh J, Lund JA, Riise T et al. Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis. J Rheumatol 1992; 19: 1531-1536.
85. Nielsen GL, Faarvang KL, Thomsen BS et al. The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A randomized, double blind trial. Eur J Clin Invest 1992; 22: 687-691.
86. Faarvang KL, Nielsen GL, Thomsen BS et al. Fish oils and rheumatoid arthritis. A randomized and double-blind study. Ugeskr Laeger 1994; 156: 3495-3498.
87. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum 1994; 37: 824-829.
88. Kremer JM, Lawrence DA, Petrillo GF et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates. Arthritis Rheum 1995; 38: 1107-1114.
89. James MJ, Cleland LG. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 1997; 27: 85-97.
90. Ariza-Ariza R, Mestanza-Peralta M, Cardiel MH. Omega-3 fatty acids in rheumatoid arthritis: An overview. Semin Arthritis Rheum 1998; 27: 366-370.
91. Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol 2000; 27: 2343-2346.
92. Adam O, Beringer C, Kless T et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int 2003; 23: 27-36.
93. Remans PH, Sont JK, Wagenaar LW et al. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects. Eur J Clin Nutr 2004; 58: 839-845.
94. Berbert AA, Kondo CR, Almendra CL, Matsuo T, Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition 2005; 21: 131-136.
95. Chopra A, Lavin P, Patwardhan B, Chitre D. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an ayurvedic drug, on osteoarthritis of the knees. J Clin Rheumatol 2004; 10: 236-245.
96. Mills SY, Jacoby RK, Chacksfield M, Willoughby M. Effect of a proprietary herbal medicine on the relief of chronic arthritic pain: A double-blind study. Br J Rheumatol 1996; 35: 874-878.
97. Chrubasik C, Duke RK, Chrubasik S. The evidence for clinical efficacy of rose hip and seed: A systematic review. Phytother Res 2006; 20: 1-3.
98. Pavelka K, Gatterova J, Gollerova V, Urbanova Z, Sedlackova M, Altman RD. A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee. Osteoarthritis Cartilage 2000; 8: 335-342.
99. Glorioso S, Todesco S, Mazzi A et al. Double-blind multicentre study of the activity of S-adenosylmethionine in hip and knee osteoarthritis. Int J Clin Pharmacol Res 1985; 5: 39-49.
100. Konig B. A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. Am J Med 1987; 83: 89-94.
101. Maccagno A, Di Giorgio EE, Caston OL, Sagasta CL. Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis. Am J Med 1987; 83: 72-77.
102. Vetter G. Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis. Am J Med 1987; 83: 78-80.
103. Muller-Fassbender H. Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis. Am J Med 1987; 83: 81-83.
104. Caruso I, Pietrogrande V. Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease. Am J Med 1987; 83: 66-71.
105. di Padova C. S-adenosylmethionine in the treatment of osteoarthritis. Review of the clinical studies. Am J Med 1987; 83: 60-65.
106. Soeken KL, Lee WL, Bausell RB, Agelli M, Berman BM. Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis. J Fam Pract 2002; 51: 425-430.
107. Jung YB, Roh KJ, Jung JA et al. Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: A double-blind placebo controlled study. Am J Chin Med 2001; 29: 485-491.
108. Schmid B, Ludtke R, Selbmann HK et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial. Phytother Res 2001; 15: 344-350.
109. Biegert C, Wagner I, Ludtke R et al. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials. J Rheumatol 2004; 31: 2121-2130.
110. Singer F, Oberleitner H. Drug therapy of activated arthrosis. On the effectiveness of an enzyme mixture versus diclofenac. Wien Med Wochenschr 1996; 146: 55-58.
111. Kajiyama H, Akama H, Yamanaka H et al. One third of Japanese patients with rheumatoid arthritis use complementary and alternative medicine. Mod Rheumatol 2006; 16: 355-359.
112. Herman CJ, Dente JM, Allen P, Hunt WC. Ethnic differences in the use of complementary and alternative therapies among adults with osteoarthritis. Prev Chronic Dis 2006; 3: A80.
113. Zochling J, March L, Lapsley H etal. Use of complementary medicines for osteoarthritis - a prospective study. Ann Rheum Dis 2004; 63: 549-554.
114. Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ. Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis 2004; 1: A12.
115. Feldman DE, Duffy C, De Civita M et al. Factors associated with the use of complementary and alternative medicine in juvenile idiopathic arthritis. Arthritis Rheum 2004; 51: 527-532.
116. Hagen LE, Schneider R, Stephens D, Modrusan D, Feldman BM. Use of complementary and alternative medicine by pediatric rheumatology patients. Arthritis Rheum 2003; 49: 3-6.
117. Rao JK, Kroenke K, Mihaliak KA et al. Rheumatology patients' use of complementary therapies: Results from a one-year longitudinal study. Arthritis Rheum 2003; 49: 619-625.
118. Jang MH, Lim S, Han SM et al. Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharmacol Sci 2003; 93: 367-371.
119. Ahmed S, Anuntiyo J, Malemud CJ et al. Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: A review. Evid Based Complement Alternat Med 2005; 2: 301-308.
120. Soeken KL, Miller SA, Ernst E. Herbal medicines for the treatment of rheumatoid arthritis: A systematic review. Rheumatology 2003; 42: 652-659.
121. Setty AR, Sigal LH. Herbal medications commonly used in the practice of rheumatology: Mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum 2005; 34: 773-784.
122. Little C, Parsons T. Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst Rev 2001; 1: CD002948.
123. Ramsey SD, Spencer AC, Topolski TD, Belza B, Patrick DL. Use of alternative therapies by older adults with osteoarthritis. Arthritis Rheum 2001; 45: 222-227.
124. van Haselen RA, Graves N, Dahiha S. The costs of treating rheumatoid arthritis patients with complementary medicine: Exploring the issue. Complement Ther Med 1999; 7: 217-221.
125. Jacobs JWG, Kraaimaat FW, Bijlsma JW. Why do patients with rheumatoid arthritis use alternative treatments? Clin Rheumatol 2001; 20: 192-196.
126. Morohashi A, Satake M, Naoki H, Kaspar HF, Oshima Y, Yasumoto T. Brevetoxin B4 isolated from greenshell mussels Perna canaliculus, the major toxin involved in neurotoxic shellfish poisoning in New Zealand. Nat Toxins 1999; 7: 45-48.
127. Anttila S, Sutinen S, Paakko P, Finell B. Rheumatoid pneumoconiosis in a dolomite worker: A light and electron microscopic, and X-ray microanalytical study. Br J Dis Chest 1984; 78: 195-200.
128. Stickel F, Seitz HK. The efficacy and safety of comfrey. Public Health Nutr 2000; 3: 501-508.
129. Ishida H, Nozawa A, Nukaya H et al. Confirmation of brevetoxin metabolism in cockle, Austrovenus stutchburyi, and greenshell mussel, Perna canaliculus, associated with New Zealand neurotoxic shellfish poisoning, by controlled exposure to Karenia brevis culture. Toxicon 2004; 43: 701-712.
130. Predel HG, Giannetti B, Koll R, Bulitta M, Staiger C. Efficacy of a comfrey root extract ointment in comparison to a diclofenac gel in the treatment of ankle distortions: Results of an observer-blind, randomized, multicenter study. Phytomedicine 2005; 12: 707-714.
131. Deplazes G, Hauser SP. Mexican medicinal plants and Gruninger's diet. Documentation No.25. Schweiz Rundsch Med Prax 1990; 79: 706-708.
132. Nicolas P, Tod M, Padoin C, Petitjean O. Clinical pharmacokinetics of diacerein. Clin Pharmacokinet 1998; 35: 347-359.